CherylHarrietWatersMD

Hospital/Neurohospitalist, Movement Disorder

Professor of Neurology at CUMC

Overview of Dr. Waters

Dr. Cheryl Waters is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Burke Rehabilitation Hospital. She received her medical degree from University of Toronto Faculty of Medicine and has been in practice 37 years. She is one of 484 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. She has more than 100 publications and over 500 citings.

Office
710 W 168th St
New York, NY 10032
Book by Phone+1(440) 941-6920

Fax+1 212-305-1304

Education & Training

University of Toronto Faculty of MedicineClass of 1980
University of TorontoM.S., Pharmacology, 1977
University of TorontoB.S., Pharmacology, 1976

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 1999 - 2026
CA State Medical License 1986 - 2022
IL State Medical License 1981 - 1987
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
Top Doctors: New York Metro Area Castle Connolly, 2007-2014
New York Magazine: Top Doctors Castle Connolly, 2009
Medical Research Council of Canada (MRC) Fellowship 1985
M.D. degree with Honors, Cum Laude 1980
Frank W. Horner Silver Medal for Academic Excellence 1980
Caregiver Award USC
Super Doctor SuperDoctors.com
Join now to see all

Publications & Presentations

PubMed

Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminer...
Jace Jones-Tabah, Kathy He, Nathan Karpilovsky, Konstantin Senkevich, Ghislaine Deyab
Molecular Neurodegeneration. 2024-12-18
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Jace Jones-Tabah, Kathy He, Nathan Karpilovsky, Konstantin Senkevich, Ghislaine Deyab
Molecular Neurodegeneration. 2024-11-25
Are rare heterozygous SYNJ1 variants associated with Parkinson's disease?
Konstantin Senkevich, Sitki Cem Parlar, Cloe Chantereault, Eric Yu, Jamil Ahmad
NPJ Parkinson's Disease. 2024-10-25

Journal Articles

Common and Rare GCH1 Variants Are Associated with Parkinson's Disease
Roy N. Alcalay, Stanley Fahn, Cheryl Waters, ScienceDirect

Lectures

PD or multiple system atrophy
Montreal, Canada - 1/3/2013
Video rounds
San Diego, CA - 1/1/2013
Non Motor Symptoms and Complications in Parkinson’s Disease
Denver, Englewood, CO - 1/8/2012
Case Studies in Parkinson’s disease
Rome, Italy, 2004; Cornell Medical Center, 2012 - 1/1/2012
Case Studies in Hyperkinetic Movement Disorders
Honolulu, HI, 2003; San Francisco, CA, 2004 - 1/1/2004
Parkinson’s disease and related movement disorders in primary care
1/8/2003
Advances in Neurology
1/8/2002
Symptoms of early wearing off in Parkinson’s disease
Helsinki, Finland - 1/1/2001
Entacapona en la Enfermedad de Parkinson
Barcelona, Spain - 1/1/1999
Parkinson's disease therapy
Minneapolis, MN - 1/28/1998
Neurologic Crossfire II
San Francisco, CA - 1/24/1996
Parkinson's disease--An Update. Update in Medicine
San Diego, CA - 1/21/1996
Parkinson's disease--Not Just a Movement Disorder! Parkinson’s' disease and Movement Disorders for the Practitioner
Scottsdale, AZ - 1/18/1996
A New Management Approach to Early Parkinson's Disease: Action today for Quality tomorrow
Vienna, Austria - 1/16/1996
Management of patients with complicated Parkinson's disease
Seattle, WA - 1/7/1995
Mental Disorders in Parkinson's Disease and Clozapine and Selegiline in Parkinson's Disease: Neuroprotective or Symptomatic Effect? Advanced Courses on Parkinson's Di...
Seville, Spain - 1/30/1993
Newer Treatments in Parkinson's disease
Los Angeles, CA - 1/1/1991
Join now to see all